Publications

  • Chadha KC, Raychaudhuri SP.  Deodar fruit extract-inhibitor of Chilli mosaic virus.  Indian Phytopath 18:93, 1965.
  • Chadha KC, Raychaudhuri SP.  Interaction between sterility virus and Fusarium udum, Butl., in pigeon pea.  Indian J Agri Science 36(3):133, 1966.
  • Chadha KC, Raychaudhuri SP.  Interaction between Chilli mosaic virus and powdery mildew (Erysiphe chichoacearum).  Indian Phytopath 21:171, 1968.
  • Chadha KC, MacNeill BH.  An antiviral principle from tomato plants systemically infected with tobacco mosaic virus.  Canadian J Botany 47:513, 1968.
  • Chadha KC, MacNeill BH.  Influence of temperature upon level of virus and an antiviral principle in tomato plants systemically infected with tobacco mosaic virus.  Can J Microbiology 15(12):1469, 1969.
  • Srivastava BIS, Chadha KC.  Liberation of Agrobacterium tumifaciens DNA from tumor DNA by shearing.  Biochem Biophys Res Comm 40:968, 1970.
  • Chadha KC, Srivastava BIS.  Evidence for the presence of bacteria specific proteins in sterile crown gall tumor tissue.  Plant Physiology 48:125, 1971.
  • Srivastava BIS, Matsumoto H, Chadha KC.  Studies on chromatin-associated nucleases from barley leaves.  Plant and Cell Physiology 12:609, 1971.
  • Reyes AA, Chadha KC.  Interaction between Fusarium oxysporum f. sp. conglutinans and turnip mosaic virus in Brassica comperstris var. Chiensis seedling.  Phytopathology 62(12):1424, 1972.
  • Chadha KC, Brown SA.  Biosynthesis of phenolic acids in tomato plants infected with Agrobacterium tumifaciens.  Canadian J Botany 52:2041-2047, 1974.
  • Chadha KC, Davey MW, Byrd DM, Carter WA.  Differential production of interferon and refractoriness inducing principle in L cells.  Infect Immun 10(5):1057-1061, 1974.
  • Chadha KC, Munyon W.  Presence of herpes simplex virus antigens in transformed L cells.  J Virol 15(6):1475, 1975.
  • Allen WR, Chadha KC.  Fruit disorder of glasshouse tomatoes caused by a tobacco form of tobacco mosaic virus.  Canadian J Plant Science 55:597-604, 1975.
  • Thouless ME, Chadha KC, Munyon WH.  Serological specificity of thymidine kinase activity in herpes simplex virus transformed L cells.  Virology 60(l):350, 1976.
  • Hardi R, Hughes Jr RG, Ho YK, Chadha KC, Bardos TJ.  Differential effects of 5-methylmercapto-2'-deoxyuridine on the replication of herpes simplex virus type l in two cell systems.  Antimicrob Agents Chemother 10(4):682-686, 1976.
  • Chadha KC, Munyon WH, Zeigel RF.  Expression of type specific virion structural antigen(s) in L cells transformed by herpes simplex virus.  Virology 76:433-436, 1977.
  • Cheng Y-C, Chadha KC, Hughes Jr RG.  Biochemical and immunological characterization of deoxythymidine kinase of thymidine kinaseless HeLa cells biochemically transformed by herpes simplex virus type l.  Infec Immun 16(2):486-492, 1977.
  • Chadha KC, Munyon WH, Hughes Jr, RG.  Thymidine kinaseless revertants of Ltk- cells transformed by HSV-1 are resistant to retransformation by homologous virus.  Infec Immun 16(2):655-661, 1971.
  • Surgino WM, Chadha KC, Kingsbury DT.  Quantitation of HSV-DNA present in biochemically transformed mouse cells and their revertants.  J Gen Virol 36:111-122, 1977.
  • Chadha KC, Sclair M, Sulkowski E, Carter WA.  Molecular size heterogeneity of human leukocyte interferon.  Biochemistry 17:196-200, 1978.
  • Carter WA, Davis LR, Chadha KC, Johnson Jr, FH.  Porcine leukocyte interferon and antiviral activity in human cells.  Molec Pharmacol 15:685-690, 1979.
  • Chadha KC, Grob PM.  Affinity of human leukocyte interferon for immobilized polyribonucleotides.  Cell Biology:  International Reports 3:663-669, 1979.
  • Chadha KC, Grob PM, Mikulski AJ, Davis LR, Sulkowski E.  Copper chelate affinity chromatography of human fibroblast and leukocyte interferons.  J Gen Virol 43:701-706, 1979.
  • Grob PM, Chadha KC.  Separation of human leukocyte interferon components by Con A-Sepharose chromatography and their characterization.  Biochemistry 18:5782-5786, 1979.
  • Chadha KC, Grob PM, Hamill R, Sulkowski E.  Glycosylation of human leukocyte interferon:  effects of tunicamycin.  Arch Virol 64:109-117, 1980.
  • Dicioccio RA, Chadha KC, Srivastava BIS.  Aphidicolin:  inhibition of herpes simplex virus-induced DNA polymerase, cellular DNA polymerase alpha and virus production.  Biochim Biophys Acta 609:224-231, 1980.
  • Chadha KC, Grob PM, Hamill R, Sulkowski E.  Effects of tunicamycin on properties of human leukocyte interferon.  In:  Interferon:  Properties and Clinical Uses.  Khan, Hill and Dorn (eds), Leland Fikes Foundation Press, pp. 21-33, 1980.
  • Chadha KC, Srivastava BIS.  Comparison of the antiproliferative effects of human fibroblast and leukocyte interferons on various leukemic cell lines.  J Clin Hematol Oncol 11(2):55-60, 1981.
  • Srivastava BIS, Dicioccio RA, Chadha KC, Rinehart Jr KL.  Preferential inhibition of some cellular and virus associated nucleotide polymerases and anti herpes simplex virus activity of streptovaricin derivatives.  Antimicrob Agents Chemother 20(5):653-659, 1981.
  • Chadha KC, Sulkowski E.  Chromatography of human leukocyte interferon on controlled pore glass.  Prep Biochem ll(4):467-482, 1981.
  • Van Oss CJ, Bronson PM, Dinolfo EA, Chadha KC.  Two methods for the removal of erythrocytes from buffy coats for the production of human leukocyte interferon.  Immunol Commun 10(6):549-555, 1981.
  • Chadha KC.  Preparation of human leukocyte interferon in the presence of tunicamycin and its characterization.  In:  Methods in Enzymology, Pestka S (ed), Part A, 78:220-227, 1981.
  • Grob PM, Chadha KC.  Separation and characterization of molecular components of human leukocyte interferon by concanavalin A-agarose affinity chromatography.  In:  Methods in Enzymology, Pestka S (ed), Part A, 78:571-576, 1981.
  • Ikossi-O'Connor M, Goldrosen MH, Chadha KC.  Identification of target cell(s) responsible for production of human leukocyte interferon.  Surgical Forum 32:74, 1981.
  • Orsini F, Fitzpatrick J, Cohen E, Khurana U, Michielson C, Chadha KC, Han T, Ozer H.  The effects of long term leukapheresis on the immune system.  Vox Sanguinis 43:11-19, 1982.
  • Chadha KC, Sulkowski E.  Adsorption of human leukocyte interferon on glass:  contribution of electrostatic and hydrophobic forces.  J Interferon Res 2:229-234, 1982.
  • Thacore HR, Mount DT, Chadha KC.  Interferon system of human cornea cells:  interferon production, characterization and development of antiviral state.  J Interferon Res 2(3):401-408, 1982.
  • Baglioni C, Branca AA, D'Alessandro S, Hossenlopp D, Chadha KC.  Low interferon binding activity of two human cell lines which respond poorly to the antiviral and antiproliferative action of interferon.  Virology 122: 1982.
  • Dinolfo E, Chadha KC.  Antiviral and antiproliferative activities of three molecular components of leukocyte-derived human interferon.  Microbiol Immunol 27(7):589-599, 1983.
  • Ikossi-O'Connor MG, Chadha KC.  The effect of malignant epithelial tumors, surgical therapy and bacterial sepsis upon various parameters of interferon system.  J Surg Oncol 26(1):27-34, 1984.
  • Ikossi-O'Connor MG, Chadha KC.  Effect of splenectomy on interferon production.  Surgical Forum 57-81V, 1984.
  • Ikossi-O'Connor MG, Ambrus J, West T, Lillie MA, Milgrom H, Chadha KC.  Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma.  J Res Chem Pathol Pharmacol 45(2):271-277, 1984.
  • Dembinski WE, Chadha KC, Sulkowski E.  Purification of interferons:  an ongoing endeavor.  Proc Serono Symposia, The Interferon System, Dianzani F and Rossi GB (eds), Raven Press, pp. 1-7, 1985.
  • Chadha KC.  Acid labile human leukocyte interferon.  In:  The Interferon System.  Serono Symposia, Dianzani F and Rossi GB (eds), Raven Press, pp. 35-41, 1985.
  • Yarvin M, Thacore H, Chadha KC.  Modulation of the interferon response by adriamycin in normal and malignant human cells.  Antiviral Res 6:113-122, 1986.
  • Davis PJ, Thacore HR, Chadha KC, Lawrence WD, Kite JH.  Calmodulin in interferon preparations:  effect of interferon on calmodulin in bioactivity.  Biochem Biophys Res Comm 133(1):113-119, 1985.
  • O'Connor MGI, Chadha KC, Lillie MA, Zucker-Franklin D, Bernstein Z, Ambrus JL.  Interferon inhibitors in Patients with AIDS and AIDS unrelated Kaposi's sarcoma.  American J Med 81:783-785, 1986.
  • Ikossi MG, Ambrus JL, Chadha KC.  Regulation of in vitro human leukocyte interferon production.  Effect of prostaglandin synthetase and phosphodiesterase inhibition.  Res Commun Chem Path Pharmacol 54(3):379-393, 1986.
  • Ikossi MG, Chadha KC, Ozer H.  Characterization of Non-T effector cell subpopulations involved in production of human alpha interferon.  Immunol Inves 15(6):559-574, 1986.
  • Chadha KC, Sulkowski E.  Production and purification of natural human leukocyte interferons.  In:  The Interferon System:  A Current Review to 1987 (Baron S, Dianzani F, Stanton GJ, Fleischmann WR, eds), Univ. Texas Press, Austin, pp. 123-130, 1987.
  • Chadha KC, Ikossi MG.  Acid-labile human interferon alpha.  In:  The Interferon System:  A Current Review to 1987 (Baron S, Dianzani F, Stanton GJ, Fleischmann WR, eds), Univ. Texas Press, Austin, pp. 31-40, 1987.
  • Chadha KC, Ambrus JL, Ikossi MG.  Interferon and interferon inactivators in AIDS, ARC and cancer patients.  The Biology of the Interferon System 1986 (Cantell K, Schellekens H, eds), Martinus Nijhoff Publishers, Boston,  pp. 423-427, 1987.
  • Ambrus JL, Ambrus JL Jr, Chadha KC.  Interferon inhibitors in lupus erythematosus.  New Eng J Med 319(9):582, 1988.
  • Stoll HL III, Chadha KC.  Effect of splenectomy upon the growth of B16-F10 melanoma and its relation to the interferon system.  J Surgical Oncol 40:79-84, 1989.
  • Ambrus JL, Poiesz BJ, Lillie MA, Stadler S, DiBerardino L, Chadha KC.  Interferon and interferon inhibitors in patients infected with varicella-zoster virus, AIDS, ARC, Kaposi's sarcoma and normal individuals.  The American J Medicine 87:405-407, 1989.
  • Mahafzah M, Stadler S, Ambrus JL, Chadha KC.  Effect of meclomen on production and action of human interferon alpha.  Acta Virologica 34:26-34, 1990.
  • Lin H-Y, Davis PJ, Davis FB, Chadha KC, Thacore HR.  Effect of calmodulin antagonists on the interferon system:  induction and action of interferons.  J Interferon Res 10:39-46, 1990.
  • Chadha KC, Whitney RB, Cummings MK, Norman M, Windle M, Stadler I.  Evaluation of interferon system among chronic alcoholics.  In:  Seminara D, Watson W, Pawlowski A (eds), Alcohol Immunodulation and AIDS Proceedings, Alan R. Liss, Inc., NY, pp. 123-133, 1990.
  • Chadha KC, Ambrus JL, Halpern J, Khalil M, Sayyid S, Pier MS, Hreshchyshyn MM.  The interferon system in gnyecological cancer:  effect of radiation and chemotherapy.  Cancer 67:87, 1991.
  • Chadha KC, Ambrus JL, Stadler I, Ambrus Jr JL.  Interferon inhibitor in the blood of patients with systemic lupus erythrematosus.  J Biol  Regulators & Homeostatic Agents 5:1-9, 1991.
  • Aszalos A, Grimley PM, Balint E, Chadha KC, Ambrus JL.  On the mechanism of action of interferons: interaction with nonsteroidal anti-inflammatory agents pentoxifylline (Trentol) and cGMP inducers..  J Medicine 22:255-271, 1991.
  • Stadler I, Hammad A, Ambrus J, Chadha KC.  Effect of maclofenamate on natural killer cell activity.  Res Commun Chem Pathol Pharmacol 73:65-74, 1991.
  • Aszalos A, Chadha KC, Stadler I, Ambrus JL Jr, Ambrus J.  Effect of an interferon inhibitor on the antiproliferative signal of interferon-a.  Biochem. Medicine & Metabolic Biol 46:267-270, 1991.
  • Chadha KC, Stadler I, Albini B, Nabeeb S, Thacore HR.  Effect of alcohol on spleen cells and their functions in C57BL/6 mice.  Alcohol 8:481-485, 1991.
  • Ambrus JL, Chadha KC, Ambrus JL Jr.  Interfreon inhibitors in Wegner's granulomatosis.  Ann Internal Medicine 114:606-607, 1991.
  • Chadha, KC, Ambrus, JL, Halpern, J, Khalil, M, Sayyid, S, Piver, MS, Hreshchyshyn, MM. The interferon system in carcinoma of the cervix: Effect of radiation and Chemotherapy. Cancer. 67(1):87-90, 1991.
  • Windle M, Mondul T, Whitney RB, Cummins MK, Stadler I, Chadha KC.  A multivariate analysis of various interferon parameters among alcoholics and heavy smokers.  Drug & Alcohol Dependence 31:139-147, 1993.
  • Ambrus JL, Chadha KC, Anthone S, Anthone R, Sayyid S.  The alpha-interferon system in patients undergoing renal transplantation and treated with cyclosporin and prednisone.  Surgery, Gynecology and Obstetrics 176:588-590, 1993.
  • Sayyid S, Chadha KC, Anthone S, Anthone R, Halpern J, Ambrus JL.  The alpha-interferon system in cyclosporin and prednisone treated renal transplant patients.  Surgery Gynecology & Obstetrics 176:588-590, 1993.
  • Stadler I, Chadha KC, Nakeeb S, Toumbis C, Butsch J, Mathur N, Munschauer F, Vladtiu A, Satchidanand SK, Ambrus JL.  Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDS.  J Pharmacol Expt Therapeutics 268:10-13, 1994.
  • Nair MPN, Kronfol ZA, Greden JF, Chadha KC, Dumaswala UJ, Sweet AM, Schwartz SA.  Selective inhibition by alcohol and cortisol of natural killer cell activity of lymphocytes from cord blood.  Prog Neuro-psychopharmacol & Biol Psychiatry 18:1293-1305, 1994.
  • Nanak E, Vijayalakshmi MA, Chadha KC. Segregation of normal and pathological human red blood cells, lymphocytes, and fibroblasts by immobilized metal ion affinity chromatography.  J Mol Recognition 8:77-84, 1995.
  • Nair MPN, Schwartz SA, Kronfol ZA, Chadha KC. Alcohol, aging, infections and immunity.  In:  Alcohol and Aging.  Beresford T, Gomberg ES (eds), Oxford University Press, Oxford, pp. 129-134, 1995.
  • Nair MPN, Chadha KC, Stadler I, Sweet A, Schwartz SA. Differential effects of human immunodeficiency virus type I envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.  Clinical and Diagnostic Laboratory Immunology 2:434-438, 1995.
  • Chadha KC, Kazim AL, Parthasarathy R, Sulkowski E, Tomasi TB. Heparin binding sites on prions.  International J Biochromatography 2:211-223, 1997.
  • Nair MPN, Hou J, Sweet A, Schwartz SA, Chadha KC. Immunoregulatory effects of morphine on human lymphocytes.  Clin Diagn Lab Immunology 4:127-132, 1997.
  • Ambrus JL, Ambrus JL Jr, Chadha S, Novick D, Rubinstein M, Gopalakrishvani B, Bernstein Z, Priori RL, Chadha KC.  Mechanism(s) of interferon inhibitory activity in blood from patients with AIDS and patients with Lupus erythrematosus with vasculitis.  Res Commun Mole Path Pharmaco 96:255-265, 1997.
  • Ambrus JL, Chadha KC.  Nature of interferon inhibitory activity in  blood from patients with cancer, AIDS, and SLE with vasculitis.  Proc. 17th International Cancer Congress (Morals M, Brentani R, Bevilacque R, eds), p. 283-286, 1998.
  • Nair MPN, Mahajan S., Chadha KC, Hewitt R, Schwartz SA. Cocaine upregulates HIV-1 entry coreceptor,  CCR5 and downregulates HIV-1 suppressing chemokine, MIP-1b gene expression. XIII International Biophysics Congress, New Delhi, India, September 19-24, 1999.
  • Chadha K, Payne  J, Ambrus JL, Nair MPN. Mild hyperthermia modulates biological activities of interferon. XIII Interantioanl Biophysics Congress, New Delhi, India, September 19-24, 1999.
  • Nair MPN, Mahajan S, Chadha KC, Hewitt RG, Schwartz SA. Immunopathogenesis of HIV infection.  Role of Recreational Drugs.  Recent. Res. Devel. Immunology 1: 597-606, 1999.
  • Ambrus, JL, Islam, A, Akther, S, Kulaylat, M, Sykes, D, Dembinski, D, Bardoa, TJ, Ardi, J, Chadha, P and Chadha, KC. New potent interferon inducing agents: Thiolated poly (I): poly (MPC). Proc. Spring Clinical Day, State University of New York at Buffalo, 1-10,1999.
  • Chadha KC, Stadler I, Ambrus JL, Nair MPN. Effect of alcohol and MAIDS virus infection upon immunological status in C57BL/6 mice.  Recent Res Devel Immunol 2:41-51, 2000.
  • Nair MPN, Chadha KC, Hewitt RG, Mahajan S, Sweet A, Schwartz S.  Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and HIV‑1 infected patients.  Clin Diagn Lab Immunol 7:96-100, 2000. 
  • Payne J, Nair MPN, Ambrus JL, Chadha KC. Mild hyperthermia modulates biological activities of interferons. Int. J. Hyperthermia. 16:492-507, 2000.
  • Chadha KC, Sykes DE, Dembinski WE, Ambrus JL, Sr. Why do most cancer patients respond poorly to interferon therapy?  Proceedings Intl. Symposium on Recent aAdvances in Molecular Biology, Allergy & Immunology, 3-5th Sept 2000 Baroda India, pg. 179-185.
  • Nair MPN, Mahajan S, Chadha K, Nair N, Hewitt R, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA. Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. In “Neuroimmune Circuits, Drugs of Abuse and Infectious Diseases.” Adv Exp Med Biol. 493:235-40, 2001.
  • Chadha  KC, Kawinski E, Sulkowski E. Thiophilic interaction chromatography of prostate-specific antigen.  J Chromatog. B. 754(2): 521-525, 2001.
  • Kawinski E, Levine E, Chadha K. Thiophilic interaction chromatography facilities detection of various molecular complexes of prostate-specific antigen in biological fluids. Prostate 50(3): 145-153, 2002.
  • Nair MPN, Kaudaswami C, Mahajan S, Chadha KC, Chawda R, Nair N, Kumar N, Schwartz SA. The flavonoid, Quecertin, differentially regulates Th-1 (IFN-y) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochem Biophys Acta 1593(1): 29-36, 2002.
  • Aalinkeel RK, Nair MPN, Sufrin G, Mahajan SD, Chadha KC, Schwartz, SA. Antisense inhibition of the cyclo-oxygenase-2 gene modulates the expression of pro-angiogenic molecules in prostate cancer cell lines.  J Urol 169:220, 2003.
  • Ambrus JL Sr, Dembinski W, Ambrus JL Jr, Sykes DE, Akhter S, Kulaylat MN, Islam A, Chadha KC.  Free interferon -alpha/beta receptors in the circulation of patients with adenocarcinomas.  Cancer 98:2730-2733, 2003.
  • Chadha KC, Schwartz SA, Nair MPN, Demeter LR, Hewitt RG.  Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy.  Immunol Invest 32:299-312, 2003.
  • Ambrus JL Sr, Dembinski W, Ambrus JL Jr, Sykes DE, Akhter S, Kulaylat MN, Islam A, Chadha KC.  Free interferon -alpha/beta receptors in the circulation of patients with adenocarcinomas.  Cancer 98:2730-2733, 2003.
  • Chadha KC, Ambrus JL Jr, Dembinski W, Ambrus JL Sr.  Interferon and interferon inhibitory activity in disease and therapy.  Mini Review.  Exp Biol Med 229(4):285-290, 2004.
  • Sulkowski E, Chadha K, Kawinski E.  A method for detecting PSA and its molecular forms using thiophilic gel on magnetic beads.  U.S. Patent No. 6,692,643, issued February 17, 2004.
  • Aalinkeel R, Nair MPN, Sufrin G, Mahajan SD, Chadha KC, Chawda RP, Schwartz SA.  Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.  Cancer Res 64:5311-5321, 2004.
  • Chadha KC, Dembinski WE, Dunn CB, Ardi J, Bardos TJ, Dunn JA, Ambrus Sr JL.  Effect of increasing thiolation of the polycytidylic acid strand of poly I:poly C on the alpha, beta and gamma interferon inducing properties, antiviral and antiproliferative activities.  Antiviral Res. 64: 171-177, 2004.
  • Bindukumar B, Kawinski E, Cherrin C, Gambino LM, Nair MPN, Schwartz SA, Chadha KC. Two-step procedure for purification and characterization of enzymatically active prostate-specific antigen from seminal plasma. J Chromatogr B. 813: 113-120, 2004.
  • Ambrus JL Sr, Dembinski WD, Chadha Kunal, Ambrus JL Jr, Chadha KC. Resistance to interferons, Discovery Medicine, 4: 310-314, 2004.
  • Bindukumar B, Schwartz SA, Nair MP, Aalinkeel R, Kawinski E, Chadha KC.  Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.  Neoplasia 7:241-252, 2005.
  • Ambrus JL, Ambrus CM, Kulaylat MN, Dembinski W,  Akhter S and Chadha KC. Effect of nutritional status and of a carcinogenic Pox virus infection on interferon producing capacity and mortality. J. Medicine 36: 107-119, 2005.
  • Ambrus JL, Dembinski W, Chadha KC, Ambrus CM, Ambrus JL Jr, Akhter S. Interferon resistance in lung cancer patients. J. Medicine 36: 33-39, 2005
  • Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter, J Tamano-Blanco M, Abdelrahman N, Ambrus Sr J, Munschaeur F, and Ramanathan M. Interferon Inhibitory Activity in Multiple Sclerosis Patients. Arch. Neurology. 63: 1579-1584, 2006.
  • Ambrus JL Sr, Chadha KC, Islam A, Akhter S, and Ambrus JL Jr. Treatment of Viral and Neoplastic Diseases with Double-Stranded RNA Derivatives and Other New Agents. Mini Review: Soc Expt Biology & Medicine, 231: 1283-1286, 2006.
  • Ambrus CM, Kulaylat, Lillie DB, Islam A, Ambrus JL Jr, Lillie K, Chadha KC Interferons and Interferon Inhibitory Activity in Disease and Therapeutic Implications. J. Medicine 3-38: 53-71, 2006-7.
  • Sternberg Z, Weinstock-Guttman B, Hojnaki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F.  Soluble receptor for advanced glycation end products in multiple sclerosis:  a potential biomarker of disease severity.  Mult Scler, 14: 759-763, 2008.
  • Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.  Prostate, 68(16):1773-89, 2008.
  • Bindukumar B, Schwartz S, Aalinkeel R, Mahajan S, Lieberman A, Chadha K Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.  Prostate, 68(14):1531-45, 2008.
  • Satheesh Babu AK, Vijayalakshmi MA, Smith GJ, Chadha KC. Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.
  • J Chromatogr B Analyt Technol Biomed Life Sci., 861(2):227-35, 2008.
  • Sternberg Z, Chadha K, Lieberman A, Hojnacki D, Drake A, Zamboni P, Rocco P, Grazioli E, Weinstock-Guttman B, Munschauer F. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.  J Neuroimmunol, 205 (1-2): 142-7, 2008.
  • Nicotera TM, Schuster DP, Bourhim M, Chadha K, Klaich G, Corral DA. Regulation of PSA secretion and survival signaling by calcium-independent phospholipase A2 β in prostate cancer cells. The Prostate, 69: 1270-1280, 2009.
  • Sternberg Z, Chadha K, Lieberman A, Drake A, Hojnacki D, Weinstock-Guttman B, Munschauer F. . Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta. J Neuroinflammation 6:28, 2009.   
  • Sternberg Z, Hennies C, Sternberg D, Bistulfi G, Kazim L, Benedict R, Chadha,K, Leung C, Weinstock-Guttman B. Plasma Pentosidine: A potential Biomarker in the management of Multiple Sclerosis. Multiple Sclerosis. 17(2): 157-163, 2011.
  • Aalinkeel R, Bindukumar B, Schwartz SA, Smith GJ and Chadha, KC. Role of Prostate Specifdic Antigen (PSA) in Patholohgical Angiogenesis and Prostate Tumor Growth. In Horizons in Cancer Research. Volume 42 (edi) Hiroto S Watanabe. Nova Science Publishers, Inc ISBN: 978-1-61761-111-7. 2010.
  • Aalinkeel R, Bindukumar B, Reyonld JL, Sykes DE, Mahajan SD,  Chadha, K. and Schwartz SA. Over expression of MMP-9 contributes to invasiveness in Prostate Cancer cells.  Immunological Investigations, 40(5): 447-464, 2011.
  • Chadha K, Nair B, Chakravarthi S, Zhou R, Mohler JL, Schwartz SA, Aalinkeel R, Smith GJ. Enzymatic activity of free-prostate specific antigen is not required for its physiological activities.   The PROSTATE. 71:1680-1690, 2011.
  • Sternberg Z, Leung Christopher, Sternberg Daniel, Li Fan, Karmon Yuval, Chadha, Kailash and Levy, Elad. The Prevalence of Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients. CNS and Neurological Disorders-Drug Target. 12(1): 104-111, 2013.
  • Chadha KC, Miller A, Nair BK, Schwartz SA, Trump DL & Underwood W III. New Serum Biomarkers for Prostate Cancer Diagnosis. Clinical Cancer Investigation Journal. 3(1):72-79, 2014
  • Chadha KC, Nair BK, Godoy A, Nabi E, Rajnarayanan R, Schwartz S, & Smith G. Antiangiogenic activity of PSA-derived peptides. Submitted

Abstracts

  • Byrd DM, Chadha KC, Carter WA.  Production of a refractoriness inducing principal in Newcastle disease virus infected L929 cells pretreated with extracellular acid soluble cell products.  Presented at the Meeting of the American Society for Microbiology-Antimicrobial Agents and Chemotherapy.  Washington, DC, 1973.
  • Chadha KC, Munyon WH.  Detection of virus specific antigens in L-cells transformed by ultraviolet irradiated herpes simplex virus.  Presented at the Annual Meeting of American Society for Microbiology, Chicago, IL, V-199, 1974.
  • Chadha KC, Munyon WH.  Type specific virian structural antigen(s) in L-cells transformed by ultraviolet irradiated herpes simplex virus types l and 2.  Presented at the Annual Meeting of American Society for Microbiology, New York, NY, S-241, 1975.
  • Chadha KC, Munyon WH.  Resistance of transformed cells that are selected for thymidine kinaseless phenotype to retransformation by homologous herpes simplex virus type l.  Presented at the Annual Meeting of American Society for Microbiology, Atlantic City, NJ, S-ll, 1976.
  • Sheflin LG, Chadha KC, Zeigel RF, Hughes Jr. RG.  Transformation of LTK-cells to the tk+ phenotype is not effected by noninfectious or DI particles of HSV-l.  Presented at the Annual Meeting of American Society for Microbiology, New Orleans, LA, S-44, 1977.
  • Chadha KC, Sulkowski E, Carte WA.  Human leukocyte interferon: binding sites for diverse aromatic ligands.  Presented at the Annual Meeting of American Society for Microbiology, New Orleans, LA, S-73, 1977.
  • Bollin E, Chadha KC, Heine JW, Mikulski A, Sulkowski E, Vastola K, Carter WA.  Purification and characterization of some mammalian interferons.  Presented at the Symposium on Interferons and the Control of Cell-Virus Interactions, May 2-6, Rehovot, Israel, 1977.
  • Chadha KC, Sclair M, Sulkowski E, Carter WA.  Molecular size heterogeneity of human leukocyte interferon.  Presented at the Annual Meeting of American Society for Microbiology, Las Vegas, May, S-203, 1978.
  • Chadha KC, Grob P, Hamill R, Sulkowski E.  Glycosylation of interferons: human leukocyte interferon. Presented at the Annual Meeting of American Society for Microbiology, Los Angeles, May, S-81, 1979.
  • Chadha KC, Grob PM, Mikulski AJ, Davis LR, Sulkowski E. Copper chelate affinity chromatography of human fibroblast and leukocyte interferons.  Presented at the Annual Meeting of American Society for Microbiology, Los Angeles, May, S-62, 1979.
  • Chadha KC, Grob PM, Hamill R, Sulkowski E. Effects of tunicamycin on properties of human leukocyte interferon.  Presented at the International Symposium on Interferon, Wadley Institutes of Molecular Medicine, Oct. 18-20, 1979.
  • Grob PM, Chadha KC.  Separation and characterization of human leukocyte interferon components by concanavalin A-Sepharose chromatography. Presented at Conference on Regulatory Functions of Interferons.  NY Acad Sci, New York, Oct. 23-26, 1979.
  • Chadha KC, Sulkowski E.  Chromatography of human leukocyte interferon on controlled pore glass:  elution with tetraalkylammonium salts. Presented at the 2nd Annual International Congress for Interferon Research, San Francisco, CA, 1981.
  • O'Connor MI, Goldrosen MD, Chadha KC.  Identification of target cell(s) responsible for production of human leukocyte interferon.  Surgical Forum, San Francisco, CA, 1981.
  • Chadha KC.  Studies on human leukocyte interferon:  production and purification.  Life Sciences, Nov. 3-5, 1981.
  • Chadha KC, Sulkowski E.  Purification of human leukocyte-derived interferons.  Presented at the 3rd Annual International Congress for Interferon Research, Miami, FL, Nov. 1-3, 1982.
  • Bonaccio E, Pawlik L, Hossenlopp D, Chadha KC.  Human cells treated with adriamycin are less sensitive to interferon.  Presented at the 3rd Annual International Congress for Interferon Research, Miami, FL, Nov. 1-3, 1982.
  • O'Connor-Ikossi M, Chadha KC.  Inter-relationship between interferon and malignant epithelial tumors. Presented at Western New York Branch of the American Society for Microbiology, Buffalo, NY, February 1983.
  • Cohen E, Khurana U, Chadha KC, Orsini F, Fitzpatrick J, Reese PA.  HLC-A, -B and -DR locus phenotypes in relation to interferon production.  Presented at the FASEB Meeting, 43(3):372, 1984.
  • Ikossi-O'Connor MG, Ambrus J, Chadha KC.  Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma.  Presented at the Western N.Y. Branch of the American Society for Microbiology, Buffalo, NY, February 24, 1984.
  • Ambrus JL, Ikossi-O'Connor MG, Chadha KC, Biddle W, Leong S, Horoszewicz J, Attallah A, Lee JB, Ambrus CM.  Tumor against host defense mechanism (reverse immunity) interferons and their potentiators, prostaglandins, cAMP phosphodiesterases and interferon inhibitors in neoplastic diseases and AIDS.  Presented at the 9th International Convocation on Immunology, Buffalo, NY, June 25-28, 1984.
  • Ikossi-O'Connor MG, Chadha KC.  Potential for modulation of interferon system in patients with malignant disease.  TNO-ISIR Meeting on the Interferon System, Heidelberg, W. Germany, Oct. 21-25, 1984.
  • Ambrus JL, Lillie MA, West T, O’Connor M, Chadha KC. Interferon Synthesis in patients with AIDS, pre-AIDS and neoplastic diseases. Proc. SUNY at Buffalo, Dept. Medicine Annual Research Conference, 1984.
  • Ambrus JL, Ikossi-O’Connor MG, Chadha KC, Lillie MA, Milgrom H, West T, Karakousis C, Zucker-Franklin D. Changes in interferon system in cancer patients and in AIDS. Proc. Amer. Soc. Clinical Incology. 4:1, 1985
  • Ambrus JL, Ikossi-O’Conner MG, Chadha KC, Lillie MA, Milgrom H, West T, Karakousis C. Zucker-Franklin D, Ambrus CM. Changes in interferon (IFN) system in cancer patients and in AIDS. Fed. Proc. Amer. Soc. For Expt. Biology. 44:1718,1985
  • Yarvin M, Chadha KC.  Influence of adriamycin on production and antiviral action of interferon.  Presented at the 3rd Annual Meeting of American Society of Virology, Madison, WI, July 22-27, 1984.
  • Ikossi-O'Connor MG, Chadha KC.  Effect of splenectomy on interferon production.  Presented to the American College of Surgeons, San Francisco, CA, September. Surgical Forum, 1984.
  • Yarvin M, Thacore H, Chadha KC.  Modulation of antiviral activity by adriamycin.  Presented at the Meeting of Western N.Y. Branch of the American Society for Microbiology, Feb. 24, 1984.
  • Ambrus JL, Ikossi-O'Connor MG, Chadha KC.  Changes in interferon system in cancer patients and in AIDS.  Proc Amer Soc Clinical Oncology 4:1, 1985.
  • Davis PJ, Thacore H, Kite JH Jr., Chadha KC, Lawrence WD, Schoenl M. Calmodulin content of interferon preparation. Ann. Meeting of the Association of American Physicians. Jan 1985.
  • Ikossi-O'Connor MG, Chadha KC.  Role of prostaglandins and cyclic nucleotides in production and antiproliferative activity of human leukocyte interferon.  Presented at the 1985 TNO-ISIR Meeting on the Interferon System, Clearwater Beach, FL, Oct. 13-18, 1985.
  • Riley TF, Tebbi C, Chervinsky D, Chadha KC.  Mezerein, an inhibitor of murine neuroblastoma.  Presented at the 1985 TNO-ISIR Meeting on the Interferon System, Clearwater Beach, FL, Oct. 13-18, 1985.
  • Cohen E, Khurana U, Chadha KC, Orsini F, Fitzpatrick J.  HLA-B35 phenotype associated with acid-labile alpha interferon.  Annual Meeting, The American Society of Hematology.  Blood 66(5): Suppl. 1, 97a, 1985.
  • Cohen E, Khurana U, Chadha KC, Orsini F, Fitzpatrick, J.  HLA-B-35 phenotype association with acid-labile alpha interferon.  Blood 66(5): 97a, 1985.
  • Chadha KC, Ikossi MG, Ambrus JL.  Interferon system in healthy adults, in patients with malignant tumors and AIDS.  14th International Cancer Congress, Budapest, Hungary, Abst. #1500, Aug. 21-27, 1986.
  • Mahafzah M, Ambrus JL, Chadha KC.  Effect of Meclomen (sodium meclofenamate) on human interferon system.  14th Intl. Cancer Congress, Budapest, Hungary, Abst. #1502, Aug. 21-27, 1986.
  • Chadha KC, Ambrus JL, Ikossi MG.  Interferon and interferon inactivators in AIDS, ARC and in cancer patients.  Presented at the 1986 TNO-ISIR Meeting on the Interferon System, Espoo, Finland, Abst. #IV-ll, Sept. 7-12, 1986.
  • Stoll III H, Ikossi MD, Chadha KC.  Effect of splenectomy upon interferon induction and progression of induced malignant neoplasm.  Presented at the 1986 TNO-ISIR Meeting on the Interferon System, Espoo, Finland, Abst. #IV-43, Sept. 7-12, 1986.
  • Chadha KC.  Interferon systems in health and disease.  Presented during the Annual Meeting of Western N.Y. Branch of American Society for Microbiology, Nov., 1986.
  • Ambrus JL, Chadha KC. a interferon (IFN) in normal individuals, cancer patients and patients with AIDS. Proc. Amer. Soc. Clinical Oncology. Annual meeting, 1986.
  • Ambrus JL, Chadha KC, Mahafzah M. Interferon producing activity and interferon inhibitors in AIDS patients. Proc. SUNY at Buffalo, Medical Alumni Association, Spring Clinical Day, May 1986.
  • Ambrus JL, Halpern J, DiBerardino LA, Piver MD, Chadha KC.  Interferon and interferon inactivators in cancer patients: changes during the course of radiation treatment.  Submitted for Annual Meeting of American Association for Cancer Research, Atlanta, GA.
  • Chadha KC, Ambrus J, Halpern J.  Interferon system in cancer patients undergoing radiation therapy.  ISIR Meeting on the Interferon System, I-68.
  • Chadha KC, Stoll H.  Role of splenectomy in growth of malignant melanoma and its relation to interferon system.  Presented at the Annual Meeting of American Society of Virology, Chapel Hill, NC, May 31 to June 4, 1987.
  • Chadha KC, Melewski D, Ikossi MG.  Interferon antiproliferative activity and its relationship to intracellular levels of c-AMP and prostaglandins.  Presented at the American Society for Microbiology, WNY Branch, Buffalo, NY, Feb., 1987.
  • Ambrus JL, Ambrus CM, Stadler S, Chadha KC. Hemorheological and immunologic effects of pentoxifylline (Trental). Proc 5th European Conference of Hematology, Bordeaux, France, 7:525, 1987.
  • Ambrus CM, Chadha KC, Ikossie-O’Connor MG, Halpern J, Lillie MA,  Ambrus JL. The interferon system in AIDS and immunomodulatory effects of drugs. Proc. Xth International Congress of Pharmacology, Sydney, Australia, August 23-28, 1987.
  • Ambrus JL, Chadha KC, Sayyid S, Poiesz B, O’Connor MGI. The interferon system in normal individuals and AIDS patients. Proc 1st Canadian Research Conference, Toronto, Ontario, Canada, 1987. 
  • Chadha KC, Davis PJ, Davis FB, Thacore HR.  Modulation of intracellular calmodulin and its relationship to synthesis of human beta interferon.  Presented at the ISIR Meeting in Kyoto, Japan, Nov. 15, 1988.
  • Chadha KC, Ambrus J,  Ikossi M.  Modulation of intracellular levels of c‑AMP and Prostaglandins has no effect on antiproliferative activity of nHuIFN‑a.  Presented at ISIR Meeting in Kyoto, Japan, Nov. 15, 1988.
  • Chadha KC, Stadler I.  A unique pre-formed interferon like antiviral factor from stimulated polymorphonuclear cells.  Presented at ISIR Meeting in Kyoto, Japan, Nov. 17, 1988.
  • Chadha KC, Mahafzah KM, Stadler I, Ambrus J.  Influence of meclomen on production and action of natural human interferon alpha.  Presented at ISIR Meeting in Kyoto, Japan, Nov. 17, 1988.
  • Ambrus JL, Chadha KC, Stadler S, Ikossi M, Mahafzah MK, Lillie M.  Interferon inhibitor in AIDS-Kaposi's sarcoma, neoplastic diseases and lupus erythrematosus.  Proc 11th International Convocation on Immunology, SUNY at Buffalo, 1988.
  • Stadler S, Mahafzah M, Ambrus JL, Chadha KC. Influence of meclomen on production and action of interferon. Proc Amer Soc. Microbiology, 1988.
  • Ambrus, JL, Chadha, KC, Stadler, S, Ikossi, MG, Mahafza, MK, Lillie, MA. Interferon inhibitor in AIDS-Kaposi’s sarcoma, neoplastic disease and lupus erythematosus. Proc. 11th International convocation on Immunology, SUNY at Buffalo, 1988.
  • Ambrus JL, Stadler S, Mahafza M, Sayyid S, Chadha KC. Studies on the pathophysiology of pediatric and adult AIDS. Proc. Society of Pediatrics, 1988.
  • Tebbi C, Chadha KC, Chervinsky K.  Effects of interferon-gamma  granulocyte-macrophage colony stimulating factor and tumor necrosis factor on murine C‑1300 neuroblastoma.  Presented at the Annual Meeting of AACR, San Francisco, CA, May 24-27, 1989, #1614.
  • Lin HY, Davis PJ, Davis FB, Chadha KC, Thacore HR.  Effect of calmodulin antagonists on the interferon system:  Induction and action of interferons.  Presented at the Annual Meeting of American Society for Virology, University of Western Ontario, London, Ontario, July 9-13, 1989.
  • Chadha KC, Whitney R, Cummings M, Norman M, Windle M, Stadler I.  Evaluation of interferon system among chronic alcoholics.  Presented at Alcohol and AIDS Network Conference, Tucson, Arizona, April 27-29, 1989.
  • Mondul TE, Cummings M, Aungst W, Stadler I, Chadha KC.  Interferon status in heavy cigarette smokers.  Presented at the Annual Meeting of American Society for Virology, University of Western Ontario, London, Ontario, July 9-13, 1989.
  • Chadha KC, Stadler I, Mondul T, Ambrus J.  Partial characterization of an interferon inactivator in the sera of patients with systemic lupus erythematosus.  Presented at the Annual Meeting of the International Society for Interferon Research, Florence, Italy, October 22-27, 1989.
  • Lin H, Davis PJ, Davis FB, Chadha KC, Thacore HR.  Effect of Calmodulin antagonists on the interferon system: Induction & action of interferons.  Presented at the Annual Meeting of the International Society for Interferon Research, Florence, Italy, October 22-27, 1989.
  • Ambrus, JL, Poieszs, BJ, Lillie, MA, Stadler, S, DiBerardino, LR, Chadha, KC. Interferon synthesis, interferon and interferon inhibitor levels in patients with varicella zoster, AIDS, ARC, Kaposi’s sarcoma and in normal individuals. Blood. 74: 397a, 1989.
  • Lin H-Y, Davis PJ, Davis FB, Chadha KC, Thacore H. Effect of Interferon antagonists in  on the interferon system : induction and action of interferons. Annual meeting of American Society of Virology, January 1989.
  • Chadha KC, Mondul T, Stadler I.  Interferon status in heavy cigarette smokers and chronic alcoholics.  Presented at the Annual Meeting of the International Society for Interferon Research, Florence, Italy, October 22-27, 1989.
  • Ambrus JL, Poiesz BJ, Lillie MA, Stadler S, DiBerardino LS, Chadha KC.  Interferon synthesis, interferon and interferon inhibitor levels in patients with Varicella-Zoster, AIDS, ARC, Kaposi's sarcoma and in normal individuals.  Blood 74:89a, 1989.
  • Chadha KC, Tebbi CK, Chervinsky D, Sato K.  In vitro and in vivo effects of   MuIFN-g, GM-CSF, TNFa and  rIL2 on murine C-1300 neuroblastoma.  Presented at the Annual Meeting of the International Society for Interferon Research, Florence, Italy, October 22-27, 1989.
  • Ambrus JL, Poiesz BJ, Lillie MA, Stadler I, DiBerardino LA, Chadha KC.  Interferon synthesis; interferon inhibitor levels in patients with varicella zoster, AIDS, ARC, Kaposi's sarcoma and in normal individuals.  Presented at the 31st Annual Meeting of the American Society of Hematology, Atlanta, GA, December 1989.
  • Chadha KC, Stadler I, Thacore HR, Mondul T, Albini B, Nakeeb SM.  Modulation of interferon system by alcohol consumption.  Presented at the 5th Congress of the International Society for Biomedical Research on Alcoholism held jointly with Research Society on Alcoholism, University of Toronto, June 17-22, 1990.
  • Ambrus JL, Stadler S, Ambrus JL Jr, Chadha KC.  The nature of the interferon inhibitor in cancer patients and patients with autoimmune disorders.  Proc Amer Assoc Cancer Res 31:58, 1990.
  • Ambrus JL, Stadler S, Halpern J, Chadha KC.  Cancer cell differentiation inducing effects of Pentoxifylline.  Proc Amer Assoc Cancer Res 30:29, 1990.
  • Stadler S, Chadha KC, Mondul T, Ambrus JL.  Interferon status in chronic alcoholics and heavy smokers.  Acta Biomed, Hung Am 2:2, 1990.
  • Ambrus JL, Chadha KC, Stadler S, Lillie MA.  The interferon system in normal individuals and patients with viral diseases including AIDS and Kaposi's sarcoma.  Effect of pentoxifylline, Indomethacin and Na-Meclofenamate.  J Clin Pharmacology 30:856, 1990.
  • Chadha KC, Stadler I, Thacore HR, Mondul T, Albini B, Nakeeb .M.  Modulation of immune cell functions due to alcohol consumption.  1990 Annual Meeting of the International Society for Interferon Research, San Francisco, CA, November 14-18, 1990.
  • Stadler I, Patterson RJ, Ambrus JL, Chadha KC.  Interferon status among substance abusers.  1990 Annual Meeting of the International Society for Interferon Research.  San Francisco, CA, November 14-18, 1990.
  • Chadha KC.  Modulation of natural killer cell activity and antibody dependent cell mediated cytotoxicity by pentoxifylline and interferon.  Presented at Annual Meeting of International Society for Interferon Research, Nice, France, Nov. 3‑8, 1991.
  • Chadha KC, Ambrus JL.  Effect of cyclosporine upon interferon production and antiviral action.  Presented at Annual Meeting of International Society for Interferon Research, Nice, France, Nov. 3-8, 1991.
  • Chadha KC.  Interferon-mediated cellular antiviral state:  different signal transduction pathways for IFN a/ß and IFN-gamma in human and murine cells.  Presented at Annual Meeting of the International Society for Interferon Research, Nice, France, Nov. 3-8, 1991.
  • Ambrus JL, Stadler S, Ambrus JL Jr, Chadha KC.  The nature of the interferon inhibitor in cancer patients and patients with autoimmune disorders.  Proc Amer Assoc Cancer Res 31:58, 1990.
  • Ambrus JL, Stadler S, Halpern J, Chadha KC.  Cancer cell differentiation inducing effect of pentoxifylline.  Proc Amer Assoc Cancer Res 30:29, 1990.
  • Ambrus JL, Chadha KC, Stadler S, Lillie MA.  Interferon system in normal individuals and patients with viral diseases including AIDS and Kaposi's sarcoma.  Effect of pentoxifylline, indomethicin and sodium meclofenamate.  J Clinical Pharmacology 30:856, 1990.
  • Ambrus JL, Chadha KC, Stadler S, Halpern J, Khalil M, Piver S, Hreschchyshyn MM.  Effect of radiation and chemotherapy on the interferon system in patients with neoplastic diseases.  Proc Soc Clinical Oncology, 1991.
  • Ambrus JL, Chadha KC, Stadler S, Halpern J, Khalil M, Piver S, Hreschchyshyn MM.  Effect of radiation and chemotherapy on the interferon system in patients with neoplastic diseases.  Proc. Amer. Soc. of Clinical Oncology, 1991.
  • Ambrus JL, Chadha KC, Stadler S, Aszalos A.  Interferon (IFN) and potential potentiating agents (pentoxifylline, indomethacin, sodium meclofenamate) in Kaposi’s Sarcoma and Burkitt’s Lymphoma.  Amer. Soc. Hematology, 1991.
  • Lin H-Y, Davis PJ, Chadha KC, Thacore H. Interferon mediated cellular antiviral state: Different signal transduction pathways for IFN-α/β  and IFN-g . Annual meeting of the International Society for Interferon Research. January 1991.
  • Ambrus JL, Stadler S, Nakeeb S, Toumbis C, Butsch J, Spatola G, Mathur N, Munschauer R, Chadha K.  Biochemical changes in Kaposi’s sarcoma and experimental therapy of murine AIDS.  Proc. AACR, 1993.
  • Ambrus JL, Stadler S, Hammad A, Aszalos A, Chadha KC.  Immune modulatory effects of pentoxifylline in patients with AIDS, neoplastic diseases and peripheral vascular diseases.  American Society of Clinical Pharmacology & Therapeutics, March 18-20, 1992.
  • Chadha KC, Zaleski MB, Stadler I, Albini B, Cunningham RK, Nakeeb S, Thacore HR.  Effect of alcohol and MAIDS virus infection upon immunological status in C57BL/6 mice.  Intl. Conference on Alcohol, Drugs of Abuse and Immunomodulation (AIDS). Tucson, Arizona, Sept. 9-12, 1992.
  • Windle M, Mondul T, Whitney RB, Cummins KM, Stadler I, Chadha KC.  A discriminant function analysis of various interferon parameters among alcoholics and heavy cigarette smokers.  International Soc for Interferon Research, Toronto, Ontario, Canada, Sept. 9-12, 1992.
  • Chadha KC, Sayyid S, Anthone S, Anthone R, Ambrus JL.  Interferon system in cyclosporin and prednisone treated renal transplant patients.  International Soc for Interferon Research, Toronto, Ontario, Canada, Sept. 9-12, 1992.
  • Stadler I, Hammad A, Chadha KC, Ambrus JL. Modulation of Natural killer cell activity and antibody dependent cell mediated cytotoxicity by Pentoxifylline and interferon. FASEB J. Vol 6, 1992
  • Zaleski MB, Thacore H, Cunningham RK, Stadler I, Zhou P, Nakeeb S, Chadha K. IL-2 driven proliferation of spleen cells from murine AIDS mice. FASEB J. January 1992.
  • Lin H-Y, Thacore H, Davis PJ, Davis FB, Chadha KC Hogan JE. Discreat signal transduction pathways are involved in induction by interferon α/β  and g of the cellular antiviral state. Clinical Research , January 1992.
  • Ambrus, JL, Stadler, S, Nakeeb, S, Toumbis, C, Butsch, C, Spatola, G, Mathur, N, Munschauer, R, Chadha, KC. Biochemical changes in Kaposi’s sarcoma and experimental therapy of murine AIDS. Proc AACR, 1993.
  • Chadha KC, Stadler I, Ambrus JL.  Interferon system changes in SLE, AIDS and cancer patients.  XVI International Cancer Congress.  New Delhi, India, Oct. 30-Nov. 5, 1994.
  • Schwartz SA, Monaco G, Chadha KC, Kumar NM, Tang X, Sweet AM, Shah M, Nair MPN.  Immunopathogenesis of HIV infection.  Role of neuropeptides.  XVI International Cancer Congress.  New Delhi, India, Nov., 1994.
  • Chadha KC, McGrath T, Sulkowski E.  Affinity of human interferons for heparin.  Annual Meeting of the International Society for Interferon and Cytokine Research.  Baltimore, MD, Nov. 6-11, 1995.
  • Nair MPN, Schwartz SA, Sweet AM, Tang X, Monaco G, Dean MA, Chadha KC.  Suppression of interferon‑g production by neonatal lymphocytes by GP‑120 from HIV‑1. Presented at Annual Meeting of the International Society for Interferon and Cytokine Research.  Baltimore, MD, Nov. 6-11, 1995.
  • Chadha KC, Stadler I, Nair MPN, Feinblatt D.  Age-related changes in NKC, ADCC and interferons.  Presented at Annual Meeting of the International Society for Interferon and Cytokine Research.  Baltimore, MD, Nov. 6-11, 1995.
  • Nair MPN, Schwartz SA, Hou J, Sweet A, Chadha KC.  Role of morphine in immunopathogenesis of HIV‑1 infection.  In:  AIDS, Drugs of Abuse and the Neuroimmune Axis.  Puerto Rico, June, 1996.
  • Nair MPN, Schwartz SA, Sweet AM, Tang X, Monaco G, Dean MA, Chadha KC.  Suppression of interferon g and a production by neonatal lymphocytes by gp120 from HIV‑1.  Cyto Res, Baltimore, 1996.
  • Chadha KC, Stadler I, Nair MPN, Feinblatt.  Age related changes in NKC, ADCC and interferons.  Int Soc Interferon Cyto Res, Baltimore, 1996.
  • Nair MPN, Hewitt RG, Whitney RB, Chadha KC, Cohn SE, Hou A, Sweet A, Schwartz SA.  Alcohol upregulates HIV‑1 entry coreceptors (CCR3 and CCR5) and downregulates HIV‑1 suppressing chemokine, MIP‑1b gene expression.  5th Annual Symposium, Drugs of Abuse, Immunomodulation and AIDS, Nashville, TN, 1997.
  • Hewitt RG, Harmon BJ, Chadha KC.  Serum interferon inhibitor declines in patients with a spectrum of HIV disease due to changes in antiretroviral therapy.  Presented at XVII International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.
  • Chadha KC, Nair MPN, Payne JL.  Mild hyperthermia modulates biological activities of interferons. Presented at XVII International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.
  • Ambrus JL, Chadha KC.  Nature of interferon inhibitory activity in blood from patients with cancer, AIDS and SLE with vasculitis. Presented at XVII International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.
  • Nair MPN, Chadha KC, Hewitt R, Sweet A, Schwartz SA.  Cocaine upregulates HIV-1 entry coreceptor, CCR5 and downregulates HIV-1 suppressing chemokine, MIP-1b gene expression. Presented at XVII International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.
  • Ambrus JL, Ambrus Jr JL, Ambrus CM , Chadha KC, Srivastava M.  Effect of vitamin D3, its derivatives, pentoxifylline and meclofenamic acid on in vitro and in vivo differentiation of neoplastic cells. Presented at XVII International Cancer Congress, Rio de Janeiro, Brazil, August 24-28, 1998.
  • Nair MPN, Chadha KC, Hewitt R, Sweet A, Schwartz SA.  Cocaine up regulates HIV-1 entry coreceptor, CCR5 and down regulates HIV-1 suppressing chemokine, MIP-1b gene expression.  Presented at Drugs of Abuse, Immunomodulation and AIDS.  Scottsdale, AZ, June 11-13, 1998.
  • Ambrus JL Sr, Ambrus Cm, Sykes D, Dembinski W, Bardos T, Avadi J, Chadha KC.  New potent interferon inducing agents:  thiolated poly rIrC.  Presented ISICR Meeting in Paris, France, Sept. 5-9, 1999. 
  • Chadha KC, Nair MPN, Ambrus JL Sr.  Interferon and other immune parameters of murine AIDS-infected C57BL/6 mice. Presented ISICR Meeting in Paris, France, Sept. 5-9, 1999. 
  • Nair MPN, Mahajan S, Chadha KC, Hewitt R, Schwartz SA.  Cocaine upregulates HIV-1 entry coreceptors, CCR5 and down regulates HIV-1 suppressing chemokines MIP-1$.  Presented XIII International Biophysics Congress, New Delhi, India, Sept. 19-24, 1999. 
  • Chadha KC, Payne J, Ambrus JL, Nair MPN.  Mild hyperthermia modulates biological activities of interferons. Presented XIII International Biophysics Congress, New Delhi, India, Sept. 19-24, 1999. 
  • Ambrus JL, Ambrus CM, Chadha KC, Bardos TJ, Sykes D.  Interferon resistance in cancer patients. Asia-Pacific Cancer Congress, Madras, India, Dec. 12-15, 1999.
  • Ambrus JL, Islam A, Ashter S, Kulaylat M, Sykes D, Dembinski D, Bardos TJ, Aradi J, Chadha KC,  Chadha P. Circulating free interferon receptors in cancer patients. Proc Spring Clinical Day, State University of NY at Buffalo, 1999.
  • Aalinkeel RK, Nair MPN, Sufrin G, Mahajan S, Chadha KC, Redfern R, Schwartz SA. Cyclooxygenase (COX)-2 expression in metastatic prostate cancer cell lines and modulation of its expression using antisense oligonucleotides. 94th Annual meeting, American Association for Cancer Research. Washington, DC,  July 11-14, 2003.
  • Kawinski E, Kumar BN, Huben R, Mahoney MC, Phadke S, Ambrus JL, Nair MPN, Schwartz SA, Cherrin C, Chadha KC. Levels of VEGF, IL-8, and TGF-b in patients with prostate cancer and in normal individuals. 94th Annual Meeting, American Association for Cancer Research , Washington DC, July 11-14, 2003.
  • Nair HK, Rao KVK, Chawda R, Redfern R, Aalinkeel RK, Mahajan S, Chadha KC, Schwartz SA. The flavonoid, quecertin, suppresses colony formation of prostate cancer cells by inhibiting expression of specific cell cycle genes. 94th Annual Meeting, American Association for Cancer Research, Washington, July, 11-14, 2003.
  • Aalinkeel RK, Nair MPN, Sufrin G, Mahajan S, Chadha KC, Schwartz SA. Antisense inhibition of the cyclo-oxygenase-2 gene modulates the expression of  pro-angiogenic molecules in prostate cancer cell lines. Annual Meeting, American Urology Association (AUA), April 26-May 1, 2003.
  • Bindukumar B, Schwartz SA, Aalinkeel R, Nair MPN, Cherrin C, Chadha KC.  Prostate-specific antigen (PSA) regulates production and gene expression of growth factors involved in angiogenesis.  3rd Annual Buffalo Conference on Immunology and the Boris Albini Award.  Abstract, 2003.
  • Chadha KC. Waikoloa, Hawaii 6th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Advances in Cancer Research: Molecular and Cellular Biology, Genomics and Proteomics, Targeted Therapeutics, Novel Clinical Trails, Molecular and Genetic Epidemiology/Prevention, January 24-30, 2004. Presented poster, “Prostate-specific antigen (PSA) Regulates Production and Gene Expression of Growth Factors Involved in Angiogenesis.”
  • Kumar B, Schwartz SA, Nair MPN, Aalinkeel R, Chadha KC.  Prostate specific antigen (PSA) modulates the expression of genes involved in prostate tumor growth.  Abstract submitted to the joint meeting, Cytokines in Cancer and Immunity, of the International Cytokine Society and the International Society for Interferon and Cytokine Research, San Juan, Puerto Rico, October 21-25, 2004.
  • Chadha KC. Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth. 2005 World DNA and Genome Day, April 25-29,2005, Dalian, China.
  • Chadha, KC. PSA Modulates Growth Factors Involved in Tumor Progression: A Genomic and Proteomic Study. International Cytokine Society Conference 2005, Cytokines, Immunity, Immunotherapy and Vaccine, October 27-31, Seoul, Korea, 2005.
  • B. Weinstock-Guttman, K. Chadha, R. Zivadinov, K. Bhasi, J. Muhitch, M. Tamaño-Blanco, J. Ambrus, F.E. Munschauer FE, Ramanathan M. Circulating Interferon Inhibitors May Adversely Affect Outcomes in MS Patients Who Are Anti-IFNβ Antibody Negative. Podium Presentation. American Academy of Neurology, April 1-8, 2006, San Diego. Neurology 2006; 66(S2):A251.
  • B. Weinstock-Guttman, E.A. Yeh, K. Chadha and M. Ramanathan. Interferon Inhibitory Activity as a Biological Marker of Inflammatory Demyelinating Diseases in Pediatric Population. Poster Presentation. ECTRIMS, October 12-15, Poster session 2007, Prague, Czech Republic.
  • Z. Sternberg, K. Chadha, A. Lieberman, A. Drake, D. Hojnaki, P. Zamboni, P. Rocco, E. Grazioli, B. Weinstock-Guttman, F. Munschauer.  Quercetin and Interferon-β modulate immune response(s) in Multiple Sclerosis patients: in vitro studies.  American Academy of Neurology 60th Annual Meeting, April 12 to April 19, 2008, Chicago, IL.
  • Z. Sternberg, B. Weinstock-Guttman, D. Hojnaki, P. Zamboni, R. Zivadinov, K. Chadha, A. Lieberman, L. Kazim, A. Drake, P. Rocco, E. Grazioli, F. Munschauer.  Soluble Receptor for Advanced Glycation End Products in Multiple Sclerosis: A Potential Biomarker of Disease Severity.  American Academy of Neurology 60th Annual Meeting, April 12 to April 19, 2008, Chicago, IL.
  • Z. Sternberg, K. Chadha, A. Liberman, A. Drake, D. Hojnaki, B. Weinstock-Guttman, F. Munschauer. Luteolin and Interferon-β modulate immune response(s) in peripheral blood mononuclear cells from multiple sclerosis patients. 61st American Academy of Neurology Annual Meeting, April 25-May 2, 2009 Seattle, Washington
  • Chadha KC, Sternberg Z, Lieberman A, Drake A, Weinstoch-Guttman B, Munschauer F. Immunomodulation by quercetin and interferon-β in multiple sclerosis patients. Tri-Society Annual Conference. Cellular and Cytokine Interactions in Health & Disease. October 18-21, 2009, Lisbon, Portugal.
  • Chadha KC. Vellore Institute of Technology, VIT University, Department of Biotechnology. Prostate Specific Antigen (PSA): Past, Present and Future, Vellore, India, Dec 1-3, 2010.
  • Chadha, KC. EPS Global International Cancer Forum, Daping Hospital and Institute of Surgery Research, Third Military Medical University, Prostate Specific Antigen: Where we are and where we are Going. Keynote lecture, Chongqing, China. November 12, 2010.
  • Chadha KC. International Symposium on Kallikreins and Kallikreins Related Peptidases (ISK2011). Enzymatic activity of PSA is not Required for its Enzymatic Activity, Rhodes Island, Greece, Sept 2-4, 2011.
  • Mrabet N, Chadha K, Satheesh Babu AK, Vijayalakshmi MA. Prostate-Specific Antigen: Serine protease activity and zinc inhibition-kinetic and structural aspects. Affinity 2011-Meeting of the International Society for Molecular Rocognition. June 16-19, 2011, Tavira, Portugal.
  • Nair Bindukumar, Aalinkeel Ravikumar, Mahajan Supriya, Reyonld Jessica, Schwartz Stanley, Smith Gary and Chadha Kailash. PSA-derived peptides modulate growth factors involved in tumorigenesis.
  • 5th Congress of Federation of Immunological Societies of Asia Oceania. March 14-17,  2012, New Delhi, India.
  • Weinstock-Guttman Bianca, Ramanathan Murali, Zivadinov Robert, Patrick Kara, Khan Adnan, Dillon Matt, Masud Mohamed Wakas, Hojnacki David, and Chadha, Kailash. Clinical Characterization of Interferon Inhibitory Activity in Multiple Sclerosis Patients Treated with IFN-beta-1a. Presented at the annual meeting of European Committee for Research and Treatment in Multiple Sclerosis. Lyon, France, October 11-13, 2012
  • Chakravarthi Srikant, Smith Gary and Chadha Kailash. Tissue-Specific Prostate-Specific Antigen. Presented at the Annual meeting of AACR. Washington, DC, April 10, 2013. Abstract # 5306
  • Aalinkeel R, Bindukumar B, Chen C-K, Prasad PN, Cheng C, Reynold JL, Sykes DE, Mahajan SD, Chadha KC, and Schwartz S. Angiogenesis based nanotherapy for prostate cancer. Presented at the Annulal meeting of American Society for Nanomedicine.March 28-30; The Universities at Shady Grove Conference Center, Rockville, MD 20850, 2014 Chadha KC
Invited Lectures
  • Effect of tunicamycin on properties of human leukocyte interferon.  Wadley Institute of Molecular Medicine, Dallas TX, September 1980. 
  • Preparation of clinical grade human leukocyte interferon.  ASMT Seminar, Barre, VT, October 1982. 
  • Interferon system in cancer patients.  University of Bonn, Bonn, West Germany, November 1984. 
  • Purification of alpha-interferon.  The Wellcome Foundation, Kent, England, March 1985. 
  • Acid-labile leukocyte interferon.  University of Rome, Rome, Italy, October 1985. 
  • Homeostasis and cancer.  Cancer Congress, Budapest, Hungary, August 1986. 
  • Interferon system in health and disease.  WNY-ASM Lecture, State University of New York at Buffalo, Buffalo NY, October 1984. 
  • Treatment of murine neuroblastoma by interferon gamma.  Shionogi Research Laboratories, Osaka, Japan, September 1987. 
  • Interferon system among chronic alcoholics.  University of Arizona, Tucson, AZ, April 1989. 
  • Modulation of interferon system during chronic alcoholism and heavy cigarette smoking.  Louis Pasteur Center for Medical Research, Kyoto City, Japan, October 1991. 
  • Dept of Pathology, Uniformed Services, University of Health Sciences, Bethesda, MD, April 1994. 
  • Heparin affinity chromatography:  use of spermine as an affinity eluant.  Presented 13th International Symposium on Affinity Technology and Bio-Recognition, Compiegne, France, July, 1999. 
  • Seminar at AMGEN, New biomarkers for prostate cancer, Thousand Oaks, CA, June 17-19, 2002.
  • 18th UICC Intl. Cancer Congress, Oslo, Norway, July 1-7, 2002.
  • 2005 World DNA and Genome Day, April 25-29,2005, Dalian, China. Invited lecture and Chair the session on “DNA and Cancer”.
  • PSA Modulates Growth Factors Involved in Tumor Progression: A Genomic and Proteomic Study. Novel Cytokines and Cytokine Functions. International Cytokine Society Conference, 2005. October 27-30, Seoul, Korea
  • Two Faces of Prostate Specific Antigen, International Symposium Biochromatography & Nanotechnology 2007, February 11-15, 2007, Vellore Institute of Technology, Vellore, India
  • 7th World Basic Urological Research Congress, September 25-30, 2007, Dublin, Ireland. 
  • 2nd International Symposium on Kallikreins and Kallikrein-Related Peptidases, October 16—18, 2007, Athens, Greece.
  • 5th Anniversary Congress of International Drug Discovery Science and Technology (IDDST) – 2007  “Advances and Challenges Towards Major Diseases.” Invited Chair and Speaker.  November 2-10, 2007, Xi’an, China.
  • EHRLICH II-2nd World Conference on Magic Bullets.  October 1-6, 2008.  Nurnberg, Germany.
  • Seminar at the University of Binghamton, “Anti-angiogenic and Anti-tumor Activity of Prostate-Specific Antigen”, Binghamton NY November 19, 2008
  • Beijing Cancer Hospital, “Prostate-Specific Antigen-an endogenous regulator of angiogenesis” China, May 11, 2009
  • The Third Military Medical University of China Daping Hospital, “Two Faces of Prostate Specific Antigen” Chongqing, China, May 13, 2009
  • Jingzhou No 1 People Hospital, Biomarkers for early detection and management of Prostate Cancer”, Yichang, China, May 14, 2009.
  • First World Congress on Cancer 2009.  Kottayam, Kerala, India.  January 2009
  • Indo-Global Education Summit 2010, Hyderabad, India. Dec 3-7, 2010
  • Vellore Institute of Technology, VIT University, Department of Biotechnology. Prostate Specific Antigen (PSA): Past, Present and Future, Vellore, India, Dec 1-3, 2010.
  • EPS Global International Cancer Forum, Daping Hospital and Institute of Surgery Research, Third Military Medical University, Prostate Specific Antigen: Where we are and where we are Going. Keynote lecture, Chongqing, China. November 12, 2010.
  • International Symposium on Kallikreins and Kallikreins Related Peptidases (ISK2011). Enzymatic activity of PSA is not Required for its Enzymatic Activity, Rhodes Island, Greece, Sept 2-4, 2011.

 Book    

  • Interferon: Current Status, Editor: Kailash Chadha, Research Sign Post Publisher. ISBN: 81-7736-256-9, 2007.
  Book Chapters
  • Chadha KC, Grob PM, Hamill R, Sulkowski E.  Effect of tunicamycin on properties of human leukocyte interferon.  A Khan, NO Hill, GL Dorn (eds), Leland Fikes Foundation Press, Dallas, TX, pp. 21-32, 1979.
  • Grob PM, Chadha KC.  Separation and characterization of molecular components of human leukocyte interferon by concanavalin A-agarose affinity chromatography.  S Pestka (ed), Methods in Enzymology, Vol. 78, Academic Press, 1981.
  • Chadha KC.  Preparation of human leukocyte interferon in the presence of tunicamycin and its characterization.  S Pestka (ed), Methods in Enzymology, Vol. 78, Academic Press, 1981.
  • Dembinski WE, Chadha KC, Sulkowski E.  Purification of interferons: an ongoing endeavor.
  • F Dianzani, GB Rossi (eds), Raven Press, NY, pp. l-7, 1985.
  • Chadha KC.  Acid labile human leukocyte interferon.  F Dianzan GB Rossi (eds), Serono Symposia, Raven Press, NY, Vol. 24, pp. 35-41, 1985.
  • Chadha KC, Sulkowski E.  Production and purification of natural human leukocyte interferons.  S Baron, F Dianzani, GJ Stanton, WR Fleischmann Jr (eds), The Interferon System - A Current Review to 1987.  University of Texas Press, Austin, 1987.
  • Chadha KC, Ikossi MG.  Acid labile human interferon alpha.  S Baron, F Dianzani, GJ Stanton, WR Fleischmann Jr (eds), The Interferon System - A Current Review to 1987.  University of Texas Press, Austin, 1987.
  • Chadha KC, Whitney RB, Cummings MK, Norman M, Windle M, Stadler I.  Evaluation of interferon system among chronic alcoholics.  A Pawlowski, D Seminara, W Watson (eds), Immunomodulation and AIDS Proceedings. Alan R. Liss, NY, 1989.
  • Nair MPN, Schwartz SA, Kronfol ZA, Greden JF, Feinblatt DA, Sweet AM, Chadha KC.  Alcohol, aging, infections and immunity.  In:  Alcohol and Aging (T Bresford, E Gomberd, eds), Oxford Press, pp. 129-134, 1995.
  • Nair MPN, Mahajan S, Chadha KC, Hewitt RG, Schwartz SA.  Immunopathogenesis of HIV infection:  role of recreational drugs.  In:  Recent Research Developments in Immunology, S. Pandalai (ed), 1999.
  • Chadha KC, Stadler I, Ambrus JL, Nair MPN.  Effect of alcohol and MAIDS virus infection upon immunolgoical status in C57BL/6 mice.  In: Recent Research Developments in Immunology, S. Pandalai (ed), 1999. 
  • Chadha KC, Sykes SE, Dembinski WE and Ambrus JL Sr. Why do Cancer Patients Respond Poorly to Interferon Therapy? Recent Advances in Molecular Biology, Allergy and Immunology Edi: CN Ramchand, MPN Nair and P Bonny. Allied Publishers Limited. 2001
  • Aalinkeel R, Bindukumar B, Schwartz SA, Smith GJ and Chadha, KC. Role of Preostate Specifdic Antigen (PSA) in Patholohgical Angiogenesis and Prostate Tumor Growth. In Horizons in Cancer Research. Volume 42 (edi) Hiroto S Watanabe. Nova Science Publishers, Inc ISBN: 978-1-61761-111-7. 2011.
Contributions to Interferon Scientific Memoranda
  • Chadha K, Armosina M, Kane C, Grob P.  Characterization of human leukocyte interferon.  I. Affinity chromatography on poly(I) agarose.  I-A590/l, June, 1978.
  • Miller L, Chadha KC, Carter WA.  Characterization of bovine fibroblast interferon on affinity chromatography ligands.  I-A569/l, June, 1978.
  • Chadha K, Armosina M, Kane C, Grob P, Sulkowksi E.  Copper chelate chromatography of human leukocyte interferon.  A-607/l, July, 1978.
  • Grob P, Chadha K, Sclair M.  Characterization of human leukocyte interferon.  II. Chromatography on aromatic ligands.  Ia622, August, 1978.
  • Chadha KC, Grob PM, Hamill R, Sulkowski, E.  Effects of tunicamycin on properties of human leukocyte interferon.  February, 1979.
  • Grob PM, Chadha KC.  Separation and characterization of human leukocyte interferon components by concanavalin A-sepharose chromatography.  I-A723, April, 1979.
  • Chadha KC.  Thermal stability of human leukocyte interferon produced in the presence of tunicamycin.  I-A828, Nov., 1979.
  • Chadha KC, Sulkowski E.  New sorbent for hydrophobic chromatography of human leukocyte interferon.  I-A856, 1980.
  • Duigou R, Grob PM, Dinolfo E, Chadha KC.  In vitro antiviral and anti-cell growth activities of the three molecular components of human leukocyte interferon:  lung adenocarcinoma cells.  I-A873/l, Feb., 1980.
  • Brown JR, Chadha KC.  Studies on human interferon produced in a lymphoblastoid cell line apparently free from EBV genome (DG-75 cell line).  June, 1980.
  • Thacore HR, Chadha KC, Mount D.  Marked resistance of herpes simplex virus type l (HSV-l) to human interferon in human cornea cells in culture.  I-A948, August, 1980.
  • Chadha KC, Sulkowski E.  CPG chromatography of HuIFN-alpha.  July, 1981.
  • Bonaccio E, Pawlik L, Hossenlopp D, Chadha KC.  Human cells treated with adriamycin are less sensitive to interferon.  September, 1982.
  • Chadha KC, Sulkowski E.  Adsorption of leukocyte derived human interferon on glass:  contribution of electrostatic and hydrophobic forces.  I-A1127, January, 1982.
  • Landgraf S, Chadha KC.  Acid-labile human leukocyte interferon.  September, 1983.

 

Kailash C. Chadha

Associate Professor

 

  • : 716-845-3101
    Fax: 716-845-8389
  • DEPARTMENTDepartment of Molecular and Cellular Biology
    Roswell Park Cancer Institute
  • COUNTRY USA